GNRH1 and gestational diabetes: Compared to the midluteal short-acting GnRH-a long protocol, the early-follicular long-acting GnRH agonist protocol is associated with a higher incidence of gestational diabetes mellitus (3.4% vs. 1.2%), which is consistent with previous findings by Du L and Wang D (31, 32).